We are talking specifically HAART and HIV MDR Po
Post# of 155490
Cyrus stated we are still going after HIV still. For example HIV/Nash patients. We still have mono as well and HIV cure. We are talking specifically about multi drug resistance pop we went after in our HIV trial.
If you want my opinion we have a partner in Nash and just are waiting for the announcement. I’m sure I’ll get alot or slack for this but Recknor said he was working on trial design now for NASH. This was recent. We sure has hell won’t be able to fund a trial on our own. Even with 350 million shares and no big news.
Cancer sounds like we need to fund another trial on our own? I’m not sure ? I don’t know only time will tell. I’m saying this after just listening to the last CC, trying to gain clarity into our future.


CytoDyn Inc (CYDY) Stock Research Links
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com